glp-1 receptor agonist and dpp-4 inhibitor combination not recommended inhibitors for type 2 diabetes management Lesson: A Clinical Overview of
Description
showed that T2DM patients being treated with tirzepatide revealed lower MASH-related biomarkers and an increase in adiponectin, a cytokine beneficial in the regulation of glucose levels, lipid metabolism, and insulin sensitivity [10, 45, 46]
Ryder JR, Kaizer A, Rudser KD, Gross A, Kelly AS, Fox CK
Int J Mol Sci 2022;23:14631.ArticlePubMedPMC 86
GLP-1 receptors have been identified within myocardial tissue and autonomic centres [21,22,23], with murine studies demonstrating effects on heart rate, endothelial function and regulation of the autonomic nervous system [24,25,26]
GLP-1 receptor agonists are prescription medications regardless of dose
